Frutarom launches new phytopharmaceutical ingredients line

The new product line for the pharmaceutical industry expands the established EFLA brand, offering increased value to the pharmaceutical industry plus expertise in building a supply chain for sustainable, natural active pharmaceutical ingredients that meet pharmaceutical manufacturers’ needs.

The EFLApharm family of products are scientifically supported, natural, pharmaceutical-grade herbal extracts. All are produced according to strict GMP guidelines.

Examples of herbals used in traditional medicine products under the EFLApharm brand include Echinacea purpurea L (purple coneflower), Hedera helix L (common ivy) and Thymus vulgaris L (thyme), all of which are key ingredients in the growing field of cough and cold therapeutics.

“Quality continues to be a major theme across the nutritional and pharmaceutical ingredients marketplace,” said Hadar Sutovsky, global manager of the Pharma & OTC segment at the Frutarom Health Business Unit. “Companies throughout the supply chain are taking a closer look at the quality of their ingredients and trying to determine better ways to deliver finished products of the highest quality. With EFLApharm, we can simplify access to the market for pharmaceutical companies striving to launch safe and effective herbal medicines.”

• Frutarom Health BU moves into omega-3